Canada markets close in 24 minutes

DiaMedica Therapeutics Inc. (DMAC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
2.3999-0.2701 (-10.12%)
As of 03:35PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close2.6700
Open2.6500
Bid2.3800 x 800
Ask2.4000 x 2900
Day's Range2.2000 - 2.9200
52 Week Range2.2000 - 10.8800
Volume396,383
Avg. Volume167,680
Market Cap63.451M
Beta (5Y Monthly)2.41
PE Ratio (TTM)N/A
EPS (TTM)-0.7720
Earnings DateMar. 08, 2022 - Mar. 14, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est18.20
  • Business Wire

    DiaMedica Therapeutics Appoints Dr. Kirsten Gruis as Chief Medical Officer

    MINNEAPOLIS, January 05, 2022--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, announced today the appointment of Kirsten Gruis, M.D. as Chief Medical Officer. Dr. Gruis is a board-certified neurologist with 20 years of experience in both clinical medicine and drug development in large and small biopharmaceutical companies.

  • Business Wire

    DiaMedica Therapeutics Announces Participation in LifeSci Partners 11th Annual Corporate Access Event

    MINNEAPOLIS, December 13, 2021--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, announced today that the Company is participating in the LifeSci Partners 11th Annual Corporate Access Event, to be held virtually from January 5-7, 2022.

  • Business Wire

    DiaMedica Therapeutics to Present at the Piper Sandler 33rd Annual Virtual Healthcare Conference

    MINNEAPOLIS, November 17, 2021--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today announced that Rick Pauls, President and CEO, will participate in a fireside chat at the upcoming Piper Sandler 33rd Annual Virtual Healthcare Conference. Management will also be available for one-on-one meetings.